Top

Published in:

Open Access 01-12-2020 | Coronary Heart Disease | Research article

Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey

Authors: D. Goettler, M. Wagner, H. Faller, K. Kotseva, D. Wood, R. Leyh, G. Ertl, W. Karmann, P. U. Heuschmann, S. Störk, on behalf of the German EUROASPIRE IV collaborators

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Abstract

Background

Tobacco smoking is one of the most important risk factors of coronary heart disease (CHD). Hence, smoking cessation is considered pivotal in the prevention of CHD. The current study aimed to evaluate smoking cessation patterns and determine factors associated with smoking cessation in patients with established CHD.

Methods

The fourth European Survey of Cardiovascular Disease Prevention and Diabetes investigated quality of CHD care in 24 countries across Europe in 2012/13. In the German subset, smoking cessation patterns and clinical characteristics were repetitively assessed a) during index event due to CHD by medical record abstraction, b) as part of a face-to-face interview 6 to 36 months after the index event (i.e. baseline visit), and c) by telephone-based follow-up interview two years after the baseline visit. Logistic regression analysis was performed to search for factors determining smoking status at the time of the telephone interview.

Results

Out of 469 participants available for follow-up, 104 (22.2%) had been classified as current smokers at the index event. Of those, 65 patients (62.5%) had quit smoking at the time of the telephone interview, i.e., after a median observation period of 3.5 years (quartiles 3.0, 4.1). Depressed mood at baseline visit and higher education level were less prevalent amongst quitters vs non-quitters (17.2% vs 35.9%, p = 0.03 and 15.4% vs 33.3%, p = 0.03), cardiac rehabilitation programs were more frequently attended by quitters (83.1% vs 48.7%, p < 0.001), and there was a trend for a higher prevalence of diabetes at baseline visit in quitters (37.5% vs 20.5%, p = 0.07). In the final multivariable model, cardiac rehabilitation was associated with smoking cessation (OR 5.19; 95%CI 1.87 to 14.46; p = 0.002).

Discussion

Attending a cardiac rehabilitation program after a cardiovascular event was associated with smoking cessation supporting its use as a platform for smoking cessation counseling and relapse prevention.

Available only for authorised users

G. B. D. Risk Factors Collaborators, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287–323. https://doi.org/10.1016/S0140-6736(15)00128-2.CrossRef

Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al. Global, regional, and National Burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. https://doi.org/10.1016/j.jacc.2017.04.052.CrossRefPubMedPubMedCentral

Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000;160(7):939–44. https://doi.org/10.1001/archinte.160.7.939.CrossRefPubMed

Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121(6):750–8. https://doi.org/10.1161/CIRCULATIONAHA.109.891523.CrossRefPubMed

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. https://doi.org/10.1093/eurheartj/ehw106.CrossRefPubMedPubMedCentral

Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Ryden L, Amouyel P, Bruthans J, Cifkova R, Deckers JW, et al. Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE surveys, 1999-2013. Glob Heart. 2017;12(4):315–22 e313. https://doi.org/10.1016/j.gheart.2015.11.003.CrossRefPubMed

Hammal F, Ezekowitz JA, Norris CM, Wild TC, Finegan BA, Approach investigators. Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study. BMC Cardiovasc Disord. 2014;14(1):133. https://doi.org/10.1186/1471-2261-14-133.CrossRefPubMedPubMedCentral

Dawood N, Vaccarino V, Reid KJ, Spertus JA, Hamid N, Parashar S, Premier registry investigators. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med. 2008;168(18):1961–7. https://doi.org/10.1001/archinte.168.18.1961.CrossRefPubMed

Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636–48. https://doi.org/10.1177/2047487315569401.CrossRefPubMed

10.

Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Stork S, et al. Secondary prevention in younger vs. older coronary heart disease patients-insights from the German subset of the EUROASPIRE IV survey. Int J Behav Med. 2018;25(3):283–93. https://doi.org/10.1007/s12529-017-9691-y.CrossRefPubMed

11.

De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Ryden L, Gyberg V, Shahim B, Amouyel P, Bruthans J, et al. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study. Eur J Epidemiol. 2019;34(3):247–58. https://doi.org/10.1007/s10654-018-0454-0.CrossRefPubMed

12.

Authors/Task Force, Members, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035–87. https://doi.org/10.1093/eurheartj/eht108.CrossRef

13.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. https://doi.org/10.1016/s0022-3999(01)00296-3.CrossRefPubMed

14.

Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Wood D, Leyh R, Ertl G, et al. Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: a comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. Eur J Prev Cardiol. 2019;2047487319838218. https://doi.org/10.1177/2047487319838218.

15.

Sochor O, Lennon RJ, Rodriguez-Escudero JP, Bresnahan JF, Croghan I, Somers VK, Lopez-Jimenez F, Pack Q, Thomas RJ. Trends and predictors of smoking cessation after percutaneous coronary intervention (from Olmsted County, Minnesota, 1999 to 2010). Am J Cardiol. 2015;115(4):405–10. https://doi.org/10.1016/j.amjcard.2014.11.020.CrossRefPubMed

16.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, Euroaspire Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929–40. https://doi.org/10.1016/S0140-6736(09)60330-5.CrossRefPubMed

17.

Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2016;2:CD005992. https://doi.org/10.1002/14651858.CD005992.pub3.CrossRefPubMed

18.

World Health Organization. WHO framework convention on tobacco control. Geneva; 2003. Available at [https://www.who.int/fctc/en/]. Accessed 25 February 2020.

19.

Schmucker J, Wienbergen H, Seide S, Fiehn E, Fach A, Wurmann-Busch B, Gohlke H, Gunther K, Ahrens W, Hambrecht R. Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI registry. Eur J Prev Cardiol. 2014;21(9):1180–6. https://doi.org/10.1177/2047487313483610.CrossRefPubMed

20.

The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158–76. https://doi.org/10.1016/j.amepre.2008.04.009.CrossRef

21.

West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax. 2000;55(12):987–99. https://doi.org/10.1136/thorax.55.12.987.CrossRefPubMedPubMedCentral

22.

Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146. https://doi.org/10.1002/14651858.CD000146.pub3.CrossRef

23.

Balfour D, Benowitz N, Fagerstrom K, Kunze M, Keil U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J. 2000;21(6):438–45. https://doi.org/10.1053/euhj.1999.1949.CrossRefPubMed

24.

Twardella D, Brenner H. Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany. Eur J Pub Health. 2005;15(2):140–5. https://doi.org/10.1093/eurpub/cki123.CrossRef

25.

Bruthans J, Mayer O Jr, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, Cifkova R, Euroaspire IV investigators. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23(8):881–90. https://doi.org/10.1177/2047487315601078.CrossRefPubMed

26.

Snaterse M, Deckers JW, Lenzen MJ, Jorstad HT, De Bacquer D, Peters RJG, Jennings C, Kotseva K, Scholte Op Reimer WJM, Euroaspire investigators. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: a registry from the European society of cardiology. Int J Cardiol. 2018;258:1–6. https://doi.org/10.1016/j.ijcard.2018.01.064.CrossRefPubMed

27.

Caraballo RS, Kruger J, Asman K, Pederson L, Widome R, Kiefe CI, Hitsman B, Jacobs DR Jr. Relapse among cigarette smokers: the CARDIA longitudinal study - 1985-2011. Addict Behav. 2014;39(1):101–6. https://doi.org/10.1016/j.addbeh.2013.08.030.CrossRefPubMed

28.

Hoebel J, Kuntz B, Kroll LE, Finger JD, Zeiher J, Lange C, Lampert T. Trends in absolute and relative educational inequalities in adult smoking since the early 2000s: the case of Germany. Nicotine Tob Res. 2018;20(3):295–302. https://doi.org/10.1093/ntr/ntx087.CrossRefPubMed

29.

Xu X, Liu L, Sharma M, Zhao Y. Smoking-related knowledge, attitudes, behaviors, smoking cessation idea and education level among young adult male smokers in Chongqing, China. Int J Environ Res Public Health. 2015;12(2):2135–49. https://doi.org/10.3390/ijerph120202135.CrossRefPubMedPubMedCentral

30.

Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002;53(4):897–902. https://doi.org/10.1016/s0022-3999(02)00311-2.CrossRefPubMed

31.

Freedland KE, Carney RM, Skala JA. Depression and smoking in coronary heart disease. Psychosom Med. 2005;67(Suppl 1):S42–6. https://doi.org/10.1097/01.psy.0000162255.55629.9c.CrossRefPubMed

32.

Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation. 2011;123(21):2344–52. https://doi.org/10.1161/CIRCULATIONAHA.110.983536.CrossRefPubMed

33.

Kotseva K, Wood D, De Backer G, De Bacquer D, Euroaspire III study group. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20(5):817–26. https://doi.org/10.1177/2047487312449591.CrossRefPubMed

34.

Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;7:CD001800. https://doi.org/10.1002/14651858.CD001800.pub2.CrossRef

35.

Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143(9):659–72. https://doi.org/10.7326/0003-4819-143-9-200511010-00010.CrossRefPubMed

36.

Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116(10):682–92. https://doi.org/10.1016/j.amjmed.2004.01.009.CrossRefPubMed

37.

Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1:CD001800. https://doi.org/10.1002/14651858.CD001800.pub3.CrossRef

38.

Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil. 2006;13(3):369–74. https://doi.org/10.1097/01.hjr.0000199492.00967.11.CrossRefPubMed

39.

Kotseva K, Wood D, De Bacquer D, Euroaspire investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol. 2018;25(12):1242–51. https://doi.org/10.1177/2047487318781359.CrossRefPubMed

40.

Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643–53. https://doi.org/10.1016/j.annepidem.2007.03.013.CrossRefPubMed

41.

Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93. https://doi.org/10.2105/ajph.84.7.1086.CrossRefPubMedPubMedCentral

Title: Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey
Authors: D. Goettler
M. Wagner
H. Faller
K. Kotseva
D. Wood
R. Leyh
G. Ertl
W. Karmann
P. U. Heuschmann
S. Störk
on behalf of the German EUROASPIRE IV collaborators
Publication date: 01-12-2020
Publisher: BioMed Central
Keyword: Coronary Heart Disease
Published in: BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-020-01429-w

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey

Abstract

Background

Methods

Results

Discussion

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 1/2020

Intractable mechanical hemolytic anemia complicating mitral valve surgery: a case series study

Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study

Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway

Association of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of carotid atherosclerosis: a cross-sectional analysis of 730 Chinese Han adults in Chongqing

Anterior wall myocardial infarction in a 16-year-old man caused by coronary artery aneurysm during the outbreak of COVID-19

Familial dilated cardiomyopathy caused by a novel variant in the Lamin A/C gene: a case report

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page